MEDANTABSEGLOBAL HEALTH LIMITED· Healthcare ServicesHighNeutral
Announced Thu, 30 Jul, 2026 · 16:22 IST

Medanta Q1 FY27 results, Rs 0.50 dividend, Guwahati hospital to 650 beds

Revenue Growth 20pctPat NegativeEbitda Margin CompressionExceptional ItemResults View source PDFExplain this filing

MEDANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.6%Reaction day
₹1423.00
prior close
₹1390.00
announcement price
After-mkt
timing
Nifty Midcap 150market+0.5%-1.0% vs market
Hospital peers, median of 25sector-0.3%-0.3% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Midcap 150 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.1
10m
-2.2
15m
-1.6
30m
-0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.6+0.5-1.0-0.3-0.3
Next day
+1.9+1.7+0.2-0.0+1.9
2d
+0.8+1.4-0.5-0.4+1.2
3d
-1.1+1.6-2.8-0.5-0.6
4d
+2.1+1.2+0.9+0.3+1.8
5d
+2.7+1.4+1.3+1.0+1.7
1w
+1.2+1.9-0.7+0.5+0.7
15d
-0.6+1.6-2.3-3.2+2.6
1m
+4.6+2.2+2.4-4.3+8.9
2m
-3.9-5.1+1.1-7.2+3.3
3m
—————
UpDownMarket · Nifty Midcap 150Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 consolidated revenue grew 26.5 percent YoY to Rs 1,304 cr; standalone revenue up 22 percent to Rs 1,079 cr. Standalone PAT fell to Rs 137 cr from Rs 152 cr on absence of one-off gains. Board set final dividend at Rs 0.50 per share, record date Aug 14. Guwahati hospital capacity raised from 400 to 650 beds at Rs 970 cr cost, funded via internal accruals and debt over 3-4 years. New Chief Digital Officer appointed.

Likely market impact

Strong revenue growth and major capacity expansion are positives; lower PAT without one-offs and modest dividend may limit near-term excitement.